Lista de obras -

A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia

artículo científico publicado en 2004

A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults

artículo científico publicado en 2014

Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia

artículo científico publicado en 2003

Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia

artículo científico publicado en 2005

Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region

scientific article published on 01 October 2020

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia

artículo científico publicado en 2016

Clofarabine: past, present, and future

artículo científico publicado en 2007

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia

artículo científico publicado en 2016

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

artículo científico publicado en 2015

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

artículo científico publicado en 2002

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

artículo científico publicado en 2002

Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study

artículo científico publicado en 2010

No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy

artículo científico publicado en 2019

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

artículo científico publicado en 2003

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

artículo científico publicado en 2003

Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy

artículo científico publicado en 2003

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

artículo científico publicado en 2003

Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia

artículo científico publicado en 2014

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation

artículo científico publicado en 2013

The biology and therapy of adult acute lymphoblastic leukemia ⬇️

artículo científico publicado el 1 de octubre de 2003

The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study

scientific article published on 08 May 2019

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog

artículo científico publicado en 2005

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

artículo científico publicado en 2003

Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.

artículo científico publicado en 2002

Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome

artículo científico publicado en 2006

Lista de obras de

A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia

A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults

Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia

Aberrant DNA methylation of a cell cycle regulatory pathway composed of P73, P15 and P57KIP2 is a rare event in children with acute lymphocytic leukemia

Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia

Clofarabine: past, present, and future

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia

Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses

Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study

No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation

The biology and therapy of adult acute lymphoblastic leukemia ⬇️

The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study

The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.

Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome